The Long-Term Clinical Impact after Allogeneic Hematopoietic Stem Cell Transplants in Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Crises in the United States | Synapse
March 3, 2026
The Long-Term Clinical Impact after Allogeneic Hematopoietic Stem Cell Transplants in Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Crises in the United States
Key Points
Long-term outcomes show significant improvement in patients who received allogeneic hematopoietic stem cell transplants.
The study highlights a 50% reduction in recurrent vaso-occlusive crises over five years.
Observational analysis assessed data from multiple clinics across the United States.
Such findings support the effectiveness of stem cell transplants, but further studies are needed to confirm long-term benefits.